Scilex Holding (SCLX)
NASDAQ: SCLX
· Real-Time Price · USD
20.38
1.52 (8.06%)
At close: Sep 04, 2025, 3:59 PM
20.25
-0.64%
Pre-market: Sep 05, 2025, 08:57 AM EDT
8.06% (1D)
| Bid | 19.09 |
| Market Cap | 141.76M |
| Revenue (ttm) | 44.24M |
| Net Income (ttm) | -122.99M |
| EPS (ttm) | -15.54 |
| PE Ratio (ttm) | -1.31 |
| Forward PE | 6.06 |
| Analyst | Buy |
| Ask | 20.38 |
| Volume | 169,269 |
| Avg. Volume (20D) | 201,874 |
| Open | 18.92 |
| Previous Close | 18.86 |
| Day's Range | 18.51 - 20.43 |
| 52-Week Range | 3.60 - 41.30 |
| Beta | 1.33 |
About SCLX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SCLX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SCLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Scilex Holding is scheduled to release its earnings on
Jan 16, 2026,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
-17.29%
Scilex Holding shares are trading lower after the ...
Unlock content with
Pro Subscription
3 weeks ago
+18.85%
Scilex Holding shares are trading higher after the company announced it's closer to the Semnur merger after the SEC cleared registration for the Denail acquisition vote in September.
1 year ago · https://www.defenseworld.net
Sorrento Therapeutics (OTCMKTS:SRNEQ) and bluebird bio (NASDAQ:BLUE) Financial ComparisonSorrento Therapeutics (OTCMKTS:SRNEQ – Get Free Report) and bluebird bio (NASDAQ:BLUE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compar...
